Medical technology company TransMedics Group Inc (Nasdaq: TMDX) announced on Monday that it has entered into a strategic collaboration with automotive company Mercedes-Benz Group AG to establish Italy's first dedicated ground transportation network for organ transplantation.
A fleet of purpose-built Mercedes-Benz V-Class vehicles will be deployed across four National OCS Program hubs in Milan, Rome, Padua and Bari to support the use of TransMedics' Organ Care System (OCS) perfusion technology. The initiative aims to increase donor organ utilisation and expand access to transplantation.
The Italian network is expected to launch before the end of 2025, with each hub equipped with OCS Lung, Heart and Liver Systems and staffed by clinical perfusionists. Operations will be coordinated from TransMedics' National Command Center in Santa Giulia, Milan.
The partnership forms part of TransMedics' strategy to replicate its U.S. NOP model in Europe by integrating dedicated ground and air logistics with its OCS platform and clinical services, laying the groundwork for a multi-country transplant logistics network.
Roivant to announce Q3 2026 financial results
Avacta secures FDA clearance for second pre|CISION oncology programme
OncoHost receives BIG Innovation Award in Health category
Summit Therapeutics and GSK form collaboration to study ivonescimab combination therapy
Summit Therapeutics submits FDA application for ivonescimab in EGFR-mutated lung cancer
Antin to acquire clinical trial equipment provider Emsere
Merck completes acquisition of Cidara Therapeutics for USD9.2bn
Bambusa Therapeutics reports first patient dosed in proof-of-concept COPD trial
Kelun-Biotech lung cancer drug granted Breakthrough Therapy Designation in China
INOVIO's INO-3107 Biologics License Application accepted by US FDA
Sanofi and Regeneron's Dupixent gains Japan approval for paediatric asthma patients aged 6 to 11
Aqualung Therapeutics' Phase 2a lung fibrosis study approved by US FDA